Bulletin de Périodique
Journal of Psychoactive Drugs , Vol.57, n°1 - January-March 2025
Paru le :
01/03/2025
Année
2025
Page(s) :
1-128
Langue(s) :
Anglais
Discipline :
SOM (Sommaire de périodique / Journal contents)
Note de contenu :
CONTENTS:
- Efficacy and safety of four psychedelic-assisted therapies for adults with symptoms of depression, anxiety, and posttraumatic stress disorder: A systematic review and meta-analysis. Bahji A., Lunsky I., Gutierrez G., Vazquez G., p. 1-16.
- Spiritual well-being among users and non-users of psychedelics: A cross-sectional study. Garcia A.C.M., Maia L.O., Meireles E., Nogueira D.A., Tofoli L.F., p. 17-26.
- Psychedelic drug microdosing practices: A qualitative online exploration. Miller E., Bojovic V., Maddren O., Rao P., Adesina D., Petrenko A., et al., p. 27-36.
- Validation of the Danish translation of the Revised Mystical Experience Questionnaire (MEQ30) and possible impact of setting, dose and intention. Hovmand O.R., Ebbesen Jensen M., Sogaard Juul T., Korsbak Madsen M., MacDonald Fisher P., Siggaard Stenbaek D., p. 37-46.
- Association of hallucinogen persisting perception disorder with trait neuroticism and mental health symptoms. Hadley M., Halliday A., Stone J.M., p. 47-53.
- Parenting, peers, and alcohol use initiation among Black, White, and Black-White adolescents: Evidence using discrete-time survival analysis. Clark Goings T., Martinez A., Joseph P.L., Goode R., Bauer D., p. 54-61.
- Characteristics of overdose deaths related to illicitly manufactured fentanyl - Arizona, July 2019 - June 2020. Daniulaityte R., Ruhter L., Katz C., p. 62-70.
- Neurocognitive dysfunctions in people with concurrent cannabis use and opioid dependence: A cross-sectional, controlled study. Ghosh A., Shaktan A., Verma A., Basu D., Rana D.K., Nehra R., et al., p. 71-83.
- Sleep-Related Cannabis Expectancy Questionnaire (SR-CEQ): Factor analysis replication, internal reliability, and construct validity. Goodhines P.A., Rathod K., Schwarz A.A., LaRowe L.R., Wedel A.V., p. 84-98.
- Pre-post cannabis legalization for adult use: A trend study of two cohorts of young adult cannabis users in Los Angeles. Fedorova E.V., Mitchel A., Finkelstein M., Ataiants J., Wong C.F., Conn B.M., et al., p. 99-109.
- Therapeutic use and other reasons to consume cannabidiol: Insight from the French and Italian contexts. Fortin D., Di Beo V., Carrieri P., Barré T., p. 110-120.
- Suicide attempts in an Italian population with cannabis use disorders: Results of a follow-up study. Pavarin R.M., Lia L., Tugnoli S., Caracciolo S., p. 121-128.
- Efficacy and safety of four psychedelic-assisted therapies for adults with symptoms of depression, anxiety, and posttraumatic stress disorder: A systematic review and meta-analysis. Bahji A., Lunsky I., Gutierrez G., Vazquez G., p. 1-16.
- Spiritual well-being among users and non-users of psychedelics: A cross-sectional study. Garcia A.C.M., Maia L.O., Meireles E., Nogueira D.A., Tofoli L.F., p. 17-26.
- Psychedelic drug microdosing practices: A qualitative online exploration. Miller E., Bojovic V., Maddren O., Rao P., Adesina D., Petrenko A., et al., p. 27-36.
- Validation of the Danish translation of the Revised Mystical Experience Questionnaire (MEQ30) and possible impact of setting, dose and intention. Hovmand O.R., Ebbesen Jensen M., Sogaard Juul T., Korsbak Madsen M., MacDonald Fisher P., Siggaard Stenbaek D., p. 37-46.
- Association of hallucinogen persisting perception disorder with trait neuroticism and mental health symptoms. Hadley M., Halliday A., Stone J.M., p. 47-53.
- Parenting, peers, and alcohol use initiation among Black, White, and Black-White adolescents: Evidence using discrete-time survival analysis. Clark Goings T., Martinez A., Joseph P.L., Goode R., Bauer D., p. 54-61.
- Characteristics of overdose deaths related to illicitly manufactured fentanyl - Arizona, July 2019 - June 2020. Daniulaityte R., Ruhter L., Katz C., p. 62-70.
- Neurocognitive dysfunctions in people with concurrent cannabis use and opioid dependence: A cross-sectional, controlled study. Ghosh A., Shaktan A., Verma A., Basu D., Rana D.K., Nehra R., et al., p. 71-83.
- Sleep-Related Cannabis Expectancy Questionnaire (SR-CEQ): Factor analysis replication, internal reliability, and construct validity. Goodhines P.A., Rathod K., Schwarz A.A., LaRowe L.R., Wedel A.V., p. 84-98.
- Pre-post cannabis legalization for adult use: A trend study of two cohorts of young adult cannabis users in Los Angeles. Fedorova E.V., Mitchel A., Finkelstein M., Ataiants J., Wong C.F., Conn B.M., et al., p. 99-109.
- Therapeutic use and other reasons to consume cannabidiol: Insight from the French and Italian contexts. Fortin D., Di Beo V., Carrieri P., Barré T., p. 110-120.
- Suicide attempts in an Italian population with cannabis use disorders: Results of a follow-up study. Pavarin R.M., Lia L., Tugnoli S., Caracciolo S., p. 121-128.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
D. FORTIN ;
V. DI BEO ;
P. CARRIERI ;
T. BARRÉ
|
2025
Dans Journal of Psychoactive Drugs (Vol.57, n°1, January-March 2025) Article : Périodique
Dans Journal of Psychoactive Drugs (Vol.57, n°1, January-March 2025) Article : Périodique
Cannabidiol (CBD) has a wide spectrum of potential therapeutic use and is growing in popularity. However, there is a need to characterize users, as associated benefits and risks may differ depending on the pattern of use. This study explored the[...]
Historique